[HTML][HTML] Ten things to know about ten cardiovascular disease risk factors

HE Bays, PR Taub, E Epstein, ED Michos…�- American journal of�…, 2021 - Elsevier
Given rapid advancements in medical science, it is often challenging for the busy clinician to
remain up-to-date on the fundamental and multifaceted aspects of preventive cardiology and�…

American Association of Clinical Endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan—2022 update

L Blonde, GE Umpierrez, SS Reddy, JB McGill…�- Endocrine Practice, 2022 - Elsevier
Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes�…

American Association of Clinical Endocrinology Consensus Statement: comprehensive type 2 diabetes management algorithm–2023 update

SL Samson, P Vellanki, L Blonde, EA Christofides…�- Endocrine Practice, 2023 - Elsevier
Objective This consensus statement provides (1) visual guidance in concise graphic
algorithms to assist with clinical decision-making of health care professionals in the�…

[HTML][HTML] Est�ndares SEA 2022 para el control global del riesgo cardiovascular

JM Mostaza, X Pint�, P Armario, L Masana…�- Cl�nica e investigaci�n�…, 2022 - Elsevier
Resumen La Sociedad Espa�ola de Arteriosclerosis tiene entre sus objetivos contribuir al
mayor y mejor conocimiento de la enfermedad vascular, su prevenci�n y su tratamiento. Es�…

Ancestry, Lipoprotein(a), and Cardiovascular Risk Thresholds: JACC Review Topic of the Week

S Tsimikas, SM Marcovina�- Journal of the American College of Cardiology, 2022 - jacc.org
This study reviews ancestral differences in the genetics of the LPA gene, risk categories of
elevated lipoprotein (a)[Lp (a)] as defined by guidelines, ancestry-specific Lp (a) risk�…

Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo�…

S Wang, H Ren, H Zhong, X Zhao, C Li, J Ma, X Gu…�- Gut�…, 2022 - Taylor & Francis
ABSTRACT Non-fasting lipidemia (nFL), mainly contributed by postprandial lipidemia (PL),
has recently been recognized as an important cardiovascular disease (CVD) risk as fasting�…

[HTML][HTML] Ten things to know about ten cardiovascular disease risk factors–2022

HE Bays, A Agarwala, C German, P Satish…�- American Journal of�…, 2022 - Elsevier
ABSTRACT The American Society for Preventive Cardiology (ASPC)" Ten things to know
about ten cardiovascular disease risk factors–2022" is a summary document regarding�…

Lipoprotein (a) testing trends in a large academic health system in the United States

HS Bhatia, S Hurst, P Desai, W Zhu…�- Journal of the American�…, 2023 - Am Heart Assoc
Background Despite its high prevalence and clinical significance, clinical measurement of
lipoprotein (a) is rare but has not been systematically quantified. We assessed the�…

[HTML][HTML] Obesity and dyslipidemia

KR Feingold - 2015 - europepmc.org
Abnormalities in lipid metabolism are very commonly observed in patients who are obese.
Approximately 60-70% of patients with obesity are dyslipidemic. The lipid abnormalities in�…

Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: a post hoc analysis of efficacy and glycaemic control using pooled data�…

LA Leiter, M Banach, AL Catapano…�- Diabetes, Obesity�…, 2022 - Wiley Online Library
Aim To evaluate the effect of bempedoic acid on glycaemic and lipid variables in patients
with hypercholesterolaemia. Methods A patient‐level pooled analysis of four phase 3�…